2.5-MONTH EFFECTS OF A HIGH-INTENSITY LOW-CARBOHYDRATE INTERVENTION ON GLYCEMIC AND LIPID PROFILE: A TYPE-2 DIABETES NEAR-TO-REMISSION CASE STUDY OF A 65-YEAR-OLD INDIAN WOMAN WITH RECENT BILATERAL KNEE REPLACEMENT SURGERY.

Main Article Content

Abhinav Vitthalrao Pathare
Anup Bhaskarrao Chaudhary

Keywords

Older adults, Geriatrics, Low-carbohydrate, Type-2 diabetes, Eating behaviour, Eating habits, Age-friendly communication, Diabetes remission, Weight loss, Lipid profile, Metabolic health

Abstract

This case study presents the effects of approximately 2.5 months of low-carbohydrate dietary intervention in a 65-year-old woman who had chronic type-2 diabetes for approximately 4 years and had recently undergone bilateral knee replacement surgery. The intervention's primary aim was to tackle the markers of insulin resistance and type-2 diabetes. Results have demonstrated noticeable improvements in numerous important health indicators. The glycated haemoglobin (HbA1c) levels have decreased from 7.10% to 6%. Body weight has reduced from 78 kg to 71.5 kg, and Body Mass Index (BMI) has reduced from 30.46 to 27.92 kg/m2—these changes have occurred without employing calorie-deficit and exercises or increased physical activity, implying low-carbohydrate intervention’s potential in reducing weight. The lipid profile has improved—the Triglycerides (TG) to High-Density Lipoprotein (HDL) ratio, a well-established predictor of cardiovascular disease, has reduced from 4.23 to 2.65. Collectively, the results indicate low-carbohydrate intervention’s significance in managing and potentially reversing the markers of insulin resistance and type-2 diabetes.


Additionally, a positive change in eating behaviour and habits has been observed—likely because of age-friendly communication, involving family members in the consultations, encouraging positive dietary changes in the overall family members, providing various recipes, tailoring a personalised diet chart, providing guidelines to navigate through social and festive situations, and regularly repeated consultations. Although this is an approximately 2.5-month single-person case study and thus has its inherent limitations for generalisation, its results corroborate with the growing body of strong empirical evidence, suggesting the usefulness of low-carbohydrate intervention in type-2 diabetes and insulin resistance management. Furthermore, the results of this case study underline the importance of personalised dietary intervention and comprehensive support for adhering to it. 


This case study adds to the current knowledge pertaining to dietary interventions by highlighting the conceivable benefits and evident relevance of a tailored low-carbohydrate dietary intervention in improving metabolic health markers and addressing insulin resistance in an older adult with chronic type-2 diabetes. In order to validate the results of this approximately 2.5-month single-person case study and to explore the broader benefits and applicability of low-carbohydrate interventions in older adults with chronic type-2 diabetes, further research with multiple participants (larger group) is needed with long-term intervention. 


 

Abstract 229 | PDF Downloads 112

References

1. Abuyassin, B., & Laher, I. (2016). Diabetes epidemic sweeping the Arab world. World journal of diabetes, 7(8), 165. https://doi.org/10.4239%2Fwjd.v7.i8.165
2. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein, H. C., Miller, M. E., Byington, R. P., Goff, D. C., Jr, Bigger, J. T., Buse, J. B., Cushman, W. C., Genuth, S., Ismail-Beigi, F., Grimm, R. H., Jr, Probstfield, J. L., Simons-Morton, D. G., & Friedewald, W. T. (2008). Effects of intensive glucose lowering in type 2 diabetes. The New England journal of medicine, 358(24), 2545–2559. https://doi.org/10.1056/NEJMoa0802743
3. American Diabetes Association. (2019). Standards of medical care in diabetes—2019 abridged for primary care providers. Clinical diabetes: a publication of the American Diabetes Association, 37(1), 11-34. https://doi.org/10.2337%2Fcd18-0105
4. Appleton, K. M. (2016). Barriers to and facilitators of the consumption of animal-based protein-rich foods in older adults. Nutrients, 8(4), 187. https://doi.org/10.3390/nu8040187
5. Appleton, K. M. (2023). Barriers to and Facilitators of the Consumption of Animal-Based Protein-Rich Foods in Older Adults: Re-Analysis with a Focus on Sustainability. Nutrients, 15(2), 470. https://doi.org/10.3390/nu15020470
6. Best, R. L., & Appleton, K. M. (2013). The consumption of protein-rich foods in older adults: An exploratory focus group study. Journal of Nutrition Education and behavior, 45(6), 751-755. https://doi.org/10.1016/j.jneb.2013.03.008
7. Cucuzzella, M., Riley, K., & Isaacs, D. (2021). Adapting medication for type 2 diabetes to a low carbohydrate diet. Frontiers in nutrition. Volume 8. Article 688540. https://doi.org/10.3389/fnut.2021.688540
8. De La Monte, S. M., & Wands, J. R. (2008). Alzheimer's disease is type 3 diabetes—evidence reviewed. Journal of diabetes science and technology, 2(6), 1101-1113. https://doi.org/ 10.1177%2F193229680800200619
9. Diabetes UK. (n.d.). Metformin and diabetes. Retrieved from https://www.diabetes.org.uk/ guide-to-diabetes/managing-your-diabetes/treating-your-diabetes/tablets-and-medication/metformin#:~:text=Some%20people%20are%20able%20to,range%20without%20needing%20any%20medication.
10. Ebbeling, C. B., Feldman, H. A., Klein, G. L., Wong, J. M., Bielak, L., Steltz, S. K., ... & Ludwig, D. S. (2018). Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial. bmj, 363. https://doi.org/10.1136/bmj.k4583
11. Ebbeling, C. B., Swain, J. F., Feldman, H. A., Wong, W. W., Hachey, D. L., Garcia-Lago, E., & Ludwig, D. S. (2012). Effects of dietary composition on energy expenditure during weight-loss maintenance. Jama, 307(24), 2627-2634. doi:10.1001/jama.2012.6607
12. Fallabel. (2023). Stopping metformin: When and how you can stop taking metformin. Retrieved from https://diabetesstrong.com/stopping-metformin/
13. Hallberg, S. J., McKenzie, A. L., Williams, P. T., Bhanpuri, N. H., Peters, A. L., Campbell, W. W., ... & Volek, J. S. (2018). Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study. Diabetes Therapy, 9(2), 583-612. https://doi.org/10.1007/s13300-018-0373-9
14. Hu, C., & Jia, W. (2018). Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes, 67(1), 3-11. https://doi.org/10.2337/dbi17-0013
15. Iqbal, N., Vetter, M. L., Moore, R. H., Chittams, J. L., Dalton‐Bakes, C. V., Dowd, M., ... & Wadden, T. A. (2010). Effects of a low‐intensity intervention that prescribed a low‐carbohydrate vs. a low‐fat diet in obese, diabetic participants. Obesity, 18(9), 1733-1738. https://doi.org/10.1038/ oby.2009.460
16. Johnsson, K. M., Ptaszynska, A., Schmitz, B., Sugg, J., Parikh, S. J., & List, J. F. (2013). Urinary tract infections in patients with diabetes treated with dapagliflozin. Journal of Diabetes and its Complications, 27(5), 473-478. https://doi.org/10.1016/j.jdiacomp.2013.05.004
17. Kasper, J. S., & Giovannucci, E. (2006). A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiology Biomarkers & Prevention, 15(11), 2056-2062. https://doi.org/10.1158/1055-9965.epi-06-0410
18. Kelly, T., Unwin, D., & Finucane, F. (2020). Low-Carbohydrate diets in the management of obesity and type 2 diabetes: a review from clinicians using the approach in practice. International journal of environmental research and public health, 17(7), 2557. https://doi.org/10.3390/ijerph17072557
19. Kim-Dorner, S. J., Deuster, P. A., Zeno, S. A., Remaley, A. T., & Poth, M. (2009). Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance?. Metabolism: Clinical and Experimental, 59(2), 299-304. https://doi.org/10.1016/j.metabol.2009.07.027
20. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., Nathan, D. M., & Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England journal of medicine, 346(6), 393–403. https://doi.org/10.1056/NEJMoa012512
21. Liu, F., Wu, M., Feng, Y. H., Zhong, H., Cui, T. L., Huang, Y. Q., ... & Fu, P. (2013). Influence of HbA1c on short-term blood pressure variability in type 2 diabetic patients with diabetic nephropathy. Journal of Zhejiang University Science B, 14(11), 1033-1040. https://doi.org/10.1631/jzus.B1300030
22. Luz, P. L. D., Favarato, D., Faria-Neto Junior, J. R., Lemos, P., & Chagas, A. C. P. (2008). High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics, 63, 427-432. https://doi.org/10.1590%2FS180759322008000400003
23. Malhotra, A., Noakes, T., & Phinney, S. (2015). It is time to bust the myth of physical inactivity and obesity: you cannot outrun a bad diet. British journal of sports medicine, 49(15), 967-968. http://dx.doi.org/10.1136/bjsports-2015-094911
24. Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015). Prevalence of and trends in diabetes among adults in the United States, 1988-2012. Jama, 314(10), 1021-1029. https://doi.org/10.1001/jama.2015.10029
25. Metabolic Health India. (2022a). Metabolic health conference – Day 1. Retrieved from https://www.youtube.com/live/nSO9v5EJwvE?feature=shared
26. Metabolic Health India. (2022b). Metabolic health conference – Day 2. Retrieved from https://www.youtube.com/live/rxUAaB6nPSY?feature=shared
27. Metabolic Health India. (2022c). Metabolic health conference – Day 3. Retrieved from https://www.youtube.com/live/y22HeshH_6g?feature=shared
28. Mohan, V., Bhavadharini, B., Mukhopadhyay, S., Nallaperumal, S., Tiwaskar, M., Anjana, R. M., & Unnikrishnan, R. (2021). Diabetes in pre-independence India: Rediscovering a forgotten era. Journal of the Association of Physicians of India, 69, 80-84. PMID: 34472814
29. Nasri, H., & Rafieian-Kopaei, M. (2014). Metformin: current knowledge. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 19(7), 658. PMCID: PMC4214027
30. National Institute on Aging. (2023). Talking with your older patients. Retrieved from https://www.nia.nih.gov/health/talking-your-older-patients
31. Ness-Abramof, R., & Apovian, C. M. (2005). Drug-induced weight gain. Timely topics in medicine. Cardiovascular diseases, 9, E31. https://pubmed.ncbi.nlm.nih.gov/16341287/
32. Nuttall, F. Q., & Gannon, M. C. (1991). Plasma glucose and insulin response to macronutrients in nondiabetic and NIDDM subjects. Diabetes care, 14(9), 824-838. https://doi.org/10.2337/ diacare.14.9.824
33. Pathare, A. V. (2021). Exercise Does Not Solve Obesity: The" Calorie-Burning Theory" Is Misleading And Incorrect. International Journal Dental and Medical Sciences Research, 3(5), 328-333.Retrieved from http://clok.uclan.ac.uk/39920/ 1/39920%20AbhinavIJDMSR Article Editorial.pdf
34. Pathare, A. V. (2023). Improving the support for older adults in India: A multi-faceted approach for a better future. International Journal of Paediatrics and Geriatrics, 6(2), 13-17. https://doi.org/10.33545/26643685.2023.v6.i2a.206
35. Pathare, A. V., & Chaudhary, A. B. (2022). Contemporary directions in fatty liver disease in light of low-carbohydrate approach: a review by public health India. European Journal of Molecular and Clinical Medicine, 9(2), 808–817. http://publichealthindia.com/wp-content/uploads/2022/04/Ejmcm-2263.1.pdf
36. Pavy F. W. (1890). On the Principles of the Treatment of Diabetes Mellitus. The Indian Medical Gazette. Nov;25(11):327-330. PMID: 29000506; PMCID: PMC5149308. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149308/pdf/indmedgaz71145-0007.pdf
37. Playford, R. J., Pither, C., Gao, R., & Middleton, S. J. (2013). Use of the alpha-glucosidase inhibitor acarbose in patients with ‘Middleton syndrome’: Normal gastric anatomy but with accelerated gastric emptying causing postprandial reactive hypoglycemia and diarrhea. Canadian Journal of Gastroenterology, 27(7), 403-404. https://doi.org/10.1155/2013/791803
38. Reaven, G. (1999). Intensive blood pressure/glucose control in type 2 diabetes: why is it so difficult to decrease coronary heart disease?. Journal of human hypertension, 13(2), S19-S23. https://doi.org/10.1038/sj.jhh.1000830
39. Roumie, C. L., Liu, X., Choma, N. N., Greevy, R. A., Hung, A. M., Grijalva, C. G., & Griffin, M. R. (2012). Initiation of sulfonylureas versus metformin is associated with higher blood pressure at one year. Pharmacoepidemiology and drug safety, 21(5), 515-523. https://doi.org/10.1002/pds.3249
40. Saklayen, M. G. (2018). The global epidemic of the metabolic syndrome. Current hypertension reports, 20(2), 1-8. https://doi.org/10.1007/s11906-018-0812-z
41. Salazar, M. R., Carbajal, H. A., Espeche, W. G., Aizpurúa, M., Dulbecco, C. A., & Reaven, G. M. (2017). Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals. Nutrition, Metabolism and Cardiovascular Diseases, 27(4), 366-373. https://doi.org/10.1016/j.numecd.2016.12.002
42. Selvin, E., Wattanakit, K., Steffes, M. W., Coresh, J., & Sharrett, A. R. (2006). HbA1c and peripheral arterial disease in diabetes: The Atherosclerosis Risk in Communities study. Diabetes care, 29(4), 877-882. https://doi.org/10.2337/diacare.29.04.06.dc05-2018
43. Taubes, G. (2007). Good calories, bad calories: fats, carbs, and the controversial science of diet and health. Anchor.
44. Taubes, G. (2011). Why we get fat: and what to do about it. Anchor.
45. Taubes, G. (2020). The Case for Keto: The Truth about Low-Carb, High-Fat Eating. Granta Books.
46. Walton, C. M., Perry, K., Hart, R. H., Berry, S. L., & Bikman, B. T. (2019). Improvement in glycemic and lipid profiles in type 2 diabetics with a 90-day ketogenic diet. Journal of diabetes research, 2019. https://doi.org/10.1155/2019/8681959
47. Wang, C., Li, F., Guo, J., Li, C., Xu, D., & Wang, B. (2018). Insulin resistance, blood glucose and inflammatory cytokine levels are risk factors for cardiovascular events in diabetic patients complicated with coronary heart disease. Experimental and Therapeutic Medicine, 15(2), 1515-1519. https://doi.org/10.3892%2Fetm.2017.5584
48. Westman, E. C., Yancy, W. S., Mavropoulos, J. C., Marquart, M., & McDuffie, J. R. (2008). The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutrition & metabolism, 5(1), 1-9. https://doi.org/10.1186%2F1743-7075-5-36
49. Wylie, C., Copeman, J., & Kirk, S. F. L. (1999) Health and social factors affecting the food choice and nutritional intake of elderly people with restricted mobility. Journal of Human Nutrition and Dietetics, 12(5), 375-380. https://doi.org/10.1046/j.1365-277x.1999.00177.x
50. Xu, F., Zhao, L. H., Su, J. B., Chen, T., Wang, X. Q., Chen, J. F., ... & Wang, X. H. (2014). The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetology & metabolic syndrome, 6(1), 1-7. https://doi.org/10.1186/1758-5996-6-139
51. Yancy, W. S., Foy, M., Chalecki, A. M., Vernon, M. C., & Westman, E. C. (2005). A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutrition & metabolism, 2(1), 1-7. https://doi.org/10.1186%2F1743-7075-2-34
52. Yannakoulia, M., Mamalaki, E., Anastasiou, C. A., Mourtzi, N., Lambrinoudaki, I., & Scarmeas, N. (2018). Eating habits and behaviors of older people: Where are we now and where should we go?. Maturitas, 114, 14-21. https://doi.org/10.1016/j.maturitas.2018.05.001
53. Zhou, X., Perez-Cueto, F. J., Santos, Q. D., Monteleone, E., Giboreau, A., Appleton, K. M., ... & Hartwell, H. (2018). A systematic review of behavioural interventions promoting healthy eating among older people. Nutrients, 10(2), 128. https://doi.org/10.3390/nu10020128